Cedrus LLC Danaher Corp Transaction History

Cedrus LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 24, 2024	SELL	$233.08 - $265.59 $41,721 - $47,540	-179 Reduced 13.36%	1,161 $288 Million
Q2 2023 Jan 24, 2024	SELL	$224.99 - $256.14 $12,374 - $14,087	-55 Reduced 3.94%	1,340 $322 Million
Q1 2023 Jan 24, 2024	SELL	$239.75 - $277.0 $479 - $554	-2 Reduced 0.14%	1,395 $352 Million
Q4 2022 Jan 19, 2024	BUY	$241.42 - $282.29 $8,208 - $9,597	34 Added 2.49%	1,397 $371 Million
Q3 2022 Jan 19, 2024	BUY	$247.06 - $1507.4 $131,188 - $800,429	531 Added 63.82%	1,363 $352 Million
Q2 2022 Jan 19, 2024	BUY	$237.11 - $299.66 $3,319 - $4,195	14 Added 1.71%	832 $211 Million
Q1 2022 Jan 19, 2024	BUY	$257.27 - $315.76 $25,727 - $31,576	100 Added 13.93%	818 $240 Million
Q4 2021 Jan 19, 2024	BUY	$292.08 - $329.01 $209,713 - $236,229	718 New	718 $236 Million

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

Stay updated on Cedrus LLC with notifications on news.